# A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

Study · id `cardio:ct-nct03350542` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03350542](<https://clinicaltrials.gov/study/NCT03350542>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03350542

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT03350542. Allocation not applicable; no masking; primary purpose treatment. Start 2018-04-12 (actual); primary completion 2020-01-16 (actual). Results posted on 2021-02-05.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT03350542, source copy `cardio:ctgov-nct03350542-2021-05-14`, retrieved 2026-10-26)
- Started: 2018-04-12 (actual) (ClinicalTrials.gov record NCT03350542, source copy `cardio:ctgov-nct03350542-2021-05-14`, retrieved 2026-10-26)
- Primary completion: 2020-01-16 (actual) (ClinicalTrials.gov record NCT03350542, source copy `cardio:ctgov-nct03350542-2021-05-14`, retrieved 2026-10-26)
- Completion: 2021-01-08 (actual) (ClinicalTrials.gov record NCT03350542, source copy `cardio:ctgov-nct03350542-2021-05-14`, retrieved 2026-10-26)
- Results first posted: 2021-02-05 (ClinicalTrials.gov record NCT03350542, source copy `cardio:ctgov-nct03350542-2021-05-14`, retrieved 2026-10-26)
- Countries: United States; Latvia; New Zealand; United Kingdom (ClinicalTrials.gov record NCT03350542, source copy `cardio:ctgov-nct03350542-2021-05-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03350542-2021-05-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
- Acronym: EVOLVE48
- Condition: Coronary Artery Disease
- Intervention (Device): SYNERGY 48 mm
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: 22e1a0a913f707497214a35663d0932a91a4d8c0c5c7b364894eea51a88e7f35
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
